Hopes that the UK government would step in to support charity-funded medical research were dashed when the sector received no mention in the Budget despite campaigns to secure additional su
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh